Better International ETF: VXUS vs. VSS

The article compares two Vanguard international ETFs: VXUS and VSS. VSS has delivered higher annualized total returns since inception/2009 at 9.79% versus VXUS at 6.73%, but it is meaningfully more volatile because it focuses on small-cap stocks with a $2.5 billion median market cap versus $54.8 billion for VXUS. The piece frames VXUS as the more conservative choice for risk-aware investors and VSS as the higher-return, higher-risk option.

Analysis

The market takeaway is not “international vs. U.S.” but factor exposure disguised as geography. VXUS is effectively a broad, lower-beta global diversification sleeve, while VSS is a concentrated small-cap value/quality gamble on cyclical re-rating and local liquidity conditions; that means the performance gap is likely to stay highly regime-dependent rather than converge over a few quarters. In practice, VSS should outperform when global PMIs are improving, the dollar is softening, and credit is benign; VXUS should hold up better when growth is slowing or risk appetite compresses.

The biggest second-order effect is that VSS is more sensitive to funding costs and cross-border capital flows than the article implies. Small-cap ex-US equities tend to underwrite higher operational leverage with thinner margins, so a stronger USD, tighter global financial conditions, or any EM-specific stress can turn the “higher return” profile into a drawdown amplifier. VXUS is the better ballast not because it is safer in absolute terms, but because its breadth dilutes country-specific shocks and reduces dependence on any one reflation cycle.

The contrarian miss is that the higher historical return of small caps may be backward-looking compensation for a decade of discount-rate compression and a post-pandemic mean-reversion trade, not a durable structural edge. If global rates stay higher for longer, the valuation spread between large international franchises and smaller cyclical names should matter more than the article suggests, making the small-cap fund’s advantage fragile on a 12-24 month horizon. Meanwhile, the mention of NFLX and NVDA in the data is a reminder that secular growth leadership remains overwhelmingly U.S.-centric; buying ex-US equity beta is more a diversification decision than a return-maximization one.

Key Decisions for Investors

• Prefer VXUS over VSS as the core non-U.S. allocation for the next 6-12 months if the base case is slowing global growth and sticky rates; lower drawdown risk with similar fee burden.
• Use VSS tactically only as a pro-cyclical trade: initiate on a confirmed dollar rollover / global PMI inflection, with a 3-6 month horizon and willingness to tolerate higher volatility for upside capture.
• Pair trade: long VXUS / short VSS if global macro data deteriorates or if credit spreads widen; the spread should favor breadth and lower beta over small-cap cyclicality.
• For investors already overweight U.S. growth winners like NVDA/NFLX, keep international exposure in VXUS rather than reaching for VSS; it diversifies factor risk without adding as much earnings sensitivity.
• If using options, consider buying VXUS calls and financing with VSS calls only when risk appetite is improving; otherwise, the vol differential makes outright VSS exposure a poor carry trade.